uridine diphosphate has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalafalla, FG; Khalafalla, MG; Tran, HN | 1 |
| Basil, P; Choi, JM; Dang, T; Gu, F; Guillemette, C; Hovington, H; Jung, SY; Kaushik, AK; Krieger, KL; Lacombe, L; Lévesque, É; Mehdi, S; Mehra, R; Palapattu, GS; Piyarathna, DWB; Putluri, N; Putluri, V; Rasaily, U; Ravindran, A; Rowley, DR; Sonavane, R; Sreekumar, A; Wang, L; Weigel, NL | 1 |
1 review(s) available for uridine diphosphate and Prostatic Neoplasms
| Article | Year |
|---|---|
P2Y purinergic signaling in prostate cancer: Emerging insights into pathophysiology and therapy.
Topics: Humans; Male; Nucleotides; Prostatic Neoplasms; Receptors, Purinergic P2; Signal Transduction; Uridine Diphosphate | 2022 |
1 other study(ies) available for uridine diphosphate and Prostatic Neoplasms
| Article | Year |
|---|---|
Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer Patients.
Topics: Androgens; Black or African American; Glucuronosyltransferase; Humans; Male; Neoplastic Processes; Prostatic Neoplasms; Uridine Diphosphate | 2022 |